Victims: Thalidomide sold in Spain post-withdrawal

May 8, 2013 by Jorge Sainz

(AP)—Spanish victims of thalidomide on Wednesday published documents they claim prove a German drug company kept distributing the notorious drug in Spain six months after it was taken off the market in other countries.

Gruenenthal withdrew thalidomide in 1961. It had been prescribed to pregnant women mostly to combat but led to a wave of birth defects in Europe, Australia, Canada and Japan. The company has refused to accept liability, but last year it apologized to victims and has set up a fund for German ones.

The Spanish Association of Thalidomide Victims released documents it said prove the distributor delivered thalidomide tablets to Spain until May 1962.

But Gruenenthal's vice-president for corporate affairs, Frank Schonrock, insisted in comments emailed to The Associated Press that his company pulled the drug in Spain at the same time as in Germany.

The Spanish victims intend to present the documents about the distribution of thalidomide tablets when its lawsuit against Gruenenthal begins at a Madrid court on Oct. 14, said Jose Riquelme, head of the association, which has about 200 members.

The association is asking for 208 million euros ($273 million) in compensation from the German manufacturer.

"We want to get back the dignity which the Germany pharmaceutical company took from us before we were born," Riquelme told a news conference in Madrid.

Last July, an Australian woman born without arms and legs after her mother took thalidomide reached a multimillion dollar settlement with the drug's British distributor. Gruenenthal refused to settle. The lawsuit was part of a class action, and more than 100 other survivors expect to have their claims heard this year.

is still sold today, but as a treatment for , a bone marrow cancer, and .

Explore further: German drug firm makes 1st apology for thalidomide (Update)

Related Stories

German drug firm makes 1st apology for thalidomide (Update)

August 31, 2012
(AP)—The German manufacturer of a notorious drug that caused thousands of babies to be born with shortened arms and legs, or no limbs at all, issued its first ever apology Friday—50 years after pulling the drug off the ...

Australian wins millions in Thalidomide lawsuit

July 18, 2012
(AP) — An Australian woman born without arms and legs after her pregnant mother took the anti-morning sickness drug Thalidomide has reached a multimillion dollar settlement with the medicine's British distributor, her ...

Australian woman wins thalidomide hearing: court

December 19, 2011
A woman born without arms or legs on Monday won the right to have the class action she is leading against the firms behind thalidomide, a sedative blamed for birth defects, proceed in Australia.

Thalidomide maker 'ignored birth defects for years'

July 27, 2012
The German makers of thalidomide were warned of birth defects years before it was withdrawn and Australian distributors used pregnant women as the world's first test subjects, court papers alleged Friday.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.